John V. Oyler Salary and Compensation - BeOne Medicines Ltd. CEO Pay 2024

In fiscal year 2024, John V. Oyler, Co-Founder, Chairman and Chief Executive Officer of BeOne Medicines Ltd. (ONC), received total compensation of $20.8 million.

John V. Oyler's compensation breakdown includes: base salary of $1.1 million, stock awards valued at $12.0 million, option awards of $6.0 million, non-equity incentive compensation of $1.5 million, and other compensation of $197K.

Compared to fiscal year 2023, John V. Oyler's total compensation increased 10% from $18.9 million to $20.8 million.

BeOne Medicines Ltd. (ONC) Executive Pay 2024

BeOne Medicines Ltd.'s top 6 named executive officers received combined total compensation of $60.5 million in fiscal year 2024.

The named executive officers disclosed in BeOne Medicines Ltd.'s 2024 proxy statement are:John V. Oyler (Co-Founder, Chairman and Chief Executive Officer) with total compensation of $20.8 million, Dr. Xiaobin Wu (President, ChiefOperating Officer and General Manager of China) with total compensation of $11.1 million, Julia Wang (Former Chief Financial Officer) with total compensation of $10.3 million, Dr. Lai Wang (Global Head ofResearch andDevelopment) with total compensation of $7.4 million, Aaron Rosenberg (Chief Financial Officer) with total compensation of $6.2 million, and Chan Lee (Senior Vice President, General Counsel and Assistant Secretary) with total compensation of $4.7 million.